CLINICAL ROLE -
ALS Drug Target Uncovered Through CRISPR Approach
Several genes observed to protect against neuronal toxicity caused by amyotrophic lateral sclerosis.
Read More
NCI-Designated Cancer Centers Reduce Premature Mortality Among Leukemia Patients
Study suggests that supportive care may vary between National Cancer Institute-designated cancer centers and non-designated centers.
Reprogramming Skin Cells Shows Promise in Multiple Sclerosis
Induced neural stem cells may hold the key to reducing multiple sclerosis-related central nervous system damage.
Trending News Today: Insurers Report Profitability from Affordable Care Act Plans
Top news of the day from across the health care landscape.
Trending News Today: HIV/AIDS Researcher May Lead CDC
Experimental Autoimmune Drug Shows Benefits in Relapsing Multiple Sclerosis
Evobrutinib is an oral inhibitor of Bruton’s tyrosine kinase in development for several autoimmune diseases.
Precision Drug Effective in Children, Adults with Different Cancers
Experimental drug elicits response in diverse population of patients with cancer.
Trending News Today: FDA Plans to Cut Nicotine in Cigarettes
Trending News Today: Senators Now Looking into 340B Program
Drug Costs May Not Solely Drive Increasing US Health Care Spending
Administrative costs and surgical procedures may contribute significantly to overspending on health care in the United States.
Gene Regulation May Overpower Hidden HIV Reserves
Eliminating dormant HIV reserves that hide from antiretroviral therapy is key to curing the virus.
Top 3 Most Common Cognitive Effects of Multiple Sclerosis
Patients with multiple sclerosis may be at a higher risk of developing mental health conditions.
Newly Discovered Structure Could Boost Gene Therapy Efficacy
Certain amino acids may be key to delivering effective, low-dose gene therapy for neurologic conditions.
Trending News Today: Opioid Overdoses Surge Among Native Americans, Alaska Natives
Trending News Today: Michigan Settles HCV Drug Access Lawsuit
CRISPR Shows Advantages Over Targeting PCSK9 to Treat High Cholesterol
Gene-editing technology may be more effective reducing cardiovascular risks than targeting PCSK9.
Value-Based Contracts Becoming a Reality for Heart Disease Biologic
Payers may receive discounts for alirocumab (Praluent) if they agree to value-based contracts.
Quality of Life Considerations for Patients with Kidney Cancer
A newer drug may preserve quality of life better than chemotherapy for patients with renal cell carcinoma.
Trending News Today: FDA Commissioner on Frontlines of Fight Against Drug Costs
Trending News Today: Cancer Drug Costs Should Align with Value, Panel Says
Sanofi, Regeneron to Reduce Costs for PCSK9 Inhibitor for Value-Based Contracts
Payers may achieve an additional discount for alirocumab (Praluent) if they agree to value-based contracts.
Trending News Today: Economic Stress May Cause Medication Nonadherence
Trending News Today: GOP Right to Try Bill Under Fire from Top Democrat
Experimental Hydrogel Delivers Targeted Chemotherapy, Immunotherapy
Targeted administration of chemotherapy and immunotherapy may improve treatment of low-immunogenic tumors.
Fish Consumption Linked to Lower Multiple Sclerosis Risk
Intake of fish high in omega-3 fatty acids could help reduce the risk of developing multiple sclerosis or clinically isolated syndrome.
Beneficial Bacteria May Prevent Skin Cancer
A strain of Staphylococcus epidermidis may be able to reduce skin cancer growth.
Trending News Today: Walgreen Faces Class Action Lawsuit About Generic Drug Costs
Trending News Today: Cigna-Express Scripts Merger Faces Antitrust Uncertainty
Gray Matter Degeneration Linked to Multiple Sclerosis Disability
A more detailed look at gray matter atrophy may hold clues to multiple sclerosis progression.
Broadly Neutralizing Antibody Sparks Treatment-Free HIV Remission
A combination therapy that attacks the viral reservoir may be crucial to controlling HIV replication without medication.